전체포도막염 시장 규모는 향후 수년간 급성장이 전망될 예정입니다. 투자 증가, 질환에 대한 의식의 고조에 기인한다고 생각됩니다. 이 기간에 예상되는 주요 동향에는 생물학적 요법의 채용 확대, 서방형 드러그 딜리버리 시스템의 개발, 맞춤형 의료 어프로치의 확대, AI를 활용한 진단 및 치료의 진보, 저침습 수술 기술의 대두 등이 있습니다.
자가면역 질환의 유병률 증가는 향후 몇 년간의 전체포도막염 시장의 성장을 가속할 것으로 예측됩니다. 유병률의 상승은 유전적 소인, 오염이나 식생활의 변화 등의 환경적 영향, 면역계 조절 부전의 트리거가 되는 감염증이나 스트레스 요인에 대한 추가 노출 등의 요인에 기인하고 있습니다. 자가면역 질환은 자가면역 활동과 관련된 많은 사례들로 인해 면역 체계 조절에 대한 연구를 촉진함으로써 판뉴브염 치료를 발전시키고 있습니다. 2023년 5월에 영국에 본사를 둔 연구 기관인 옥스퍼드 대학교는 자가면역 질환이 세계 인구의 10%에 영향을 미치고, 여성의 13%, 남성의 7%가 영향을 받고 있다고 보고했습니다.
전체포도막염 시장의 주요 기업은 환자의 컴플라이언스와 치료 효과를 높이기 위해 첨단 서방형 유리 체내 주사 제제의 개발을 우선하고 있습니다. 체액 중에 투여하는 약물전달 시스템으로, 빈번한 투여의 필요성을 최소화하면서 치료 효과를 지속시키고 있습니다. Pharma는 망막질환 치료를 위한 잠재적인 면역조절제인 TRS02의 개발을 발표했습니다. 질병에 대처하도록 설계되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 전체포도막염 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업의 분석
- 세계의 전체포도막염 시장 : 성장률 분석
- 세계의 전체포도막염 시장 실적: 규모와 성장, 2019-2024년
- 세계의 전체포도막염 시장 예측 : 규모와 성장, 2024-2029년, 2034년
- 세계의 전체포도막염 전체 시장 규모(TAM)
제6장 시장 세분화
- 세계의 전체포도막염 시장 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 감염성 전체포도막염
- 비감염성 전체포도막염
- 세계의 전체포도막염 시장 : 치료별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 약리학
- 수술 수술
- 광선요법
- 세계의 전체포도막염 시장 : 투여 경로별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 경구
- 유리체내
- 국소
- 세계의 전체포도막염 시장 : 유통 채널별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 전체포도막염 시장 : 감염성 전 포도막염별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세균 전체포도막염
- 바이럴 전체포도막염
- 진균의 전체포도막염
- 기생적 전체포도막염
- 세계의 전체포도막염 시장 : 비감염성 전 포도막염별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 자가면역 관련 전체포도막염
- 특발성 전체포도막염
- 약제 유발성 전체포도막염
제7장 지역별/국가별 분석
- 세계의 전체포도막염 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
- 세계의 전체포도막염 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 전체포도막염 시장 : 경쟁 구도
- 전체포도막염 시장 : 기업 프로파일
- Pfizer Inc.
- AbbVie
- Boehringer Ingelheim International GmbH
- Amgen
- Teva Pharmaceuticals
제31장 기타 주요 기업 및 혁신 기업
- Sandoz
- Organon group of companies
- Zydus Lifesciences Ltd.
- Mallinckrodt plc
- Alvotech
- EyePoint Pharmaceuticals Inc.
- Affibody Medical AB
- Alumis Inc.
- Fujifilm Kyowa Kirin Biologics Co. Ltd.
- Revolo BIoTherapeutics Ltd.
- Tarsier Pharma
- Priovant Therapeutics Inc.
- Mylan NV
- Clearside Biomedical Inc.
- pSivida Corp.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
- 전체포도막염 시장, 2029년 : 새로운 기회를 제공하는 국가
- 전체포도막염 시장, 2029년 : 새로운 기회를 제공하는 부문
- 전체포도막염 시장, 2029년 : 성장 전략
제36장 부록
SHW
Panuveitis is an inflammatory condition that affects all three layers of the uvea include the iris, ciliary body, and choroid within the eye. If left untreated, it can cause pain, blurred vision, and potentially lead to vision loss. The primary goal of treatment is to control inflammation, alleviate symptoms, and prevent further eye damage that could impair vision. Timely intervention is crucial for maintaining eye health and preserving sight.
The main types of panuveitis include infectious and non-infectious panuveitis. Infectious panuveitis is caused by infectious agents and requires prompt diagnosis and treatment to prevent severe eye complications and vision impairment. Treatment options include pharmacological therapy, surgical interventions, and phototherapy, administered via oral, intravitreal, and topical routes. These treatments are distributed through hospital pharmacies, retail pharmacies, and online pharmacies, ensuring accessibility for patients.
The panuveitis market research report is one of a series of new reports from The Business Research Company that provides panuveitis market statistics, including the panuveitis industry global market size, regional shares, competitors with the panuveitis market share, detailed panuveitis market segments, market trends, and opportunities, and any further data you may need to thrive in the panuveitis industry. This panuveitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The panuveitis market size has grown rapidly in recent years. It will grow from $4.05 billion in 2024 to $4.47 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to the prevalence of autoimmune and infectious diseases, the increasing use of corticosteroids, the rising adoption of biologics, the growing demand for ophthalmic imaging, and expanding research investment in infectious causes.
The panuveitis market size is expected to see rapid growth in the next few years. It will grow to $6.58 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the expanding use of biologic therapies, increasing demand for personalized medicine, the rising prevalence of uveitis-linked diseases, higher investments in ophthalmic research, and growing disease awareness. Major trends expected during this period include the increasing adoption of biologic therapies, the development of sustained-release drug delivery systems, the expansion of personalized medicine approaches, advancements in AI-driven diagnosis and treatment, and the rise of minimally invasive surgical techniques.
The increasing prevalence of autoimmune disorders is expected to drive the growth of the panuveitis market in the coming years. Autoimmune diseases occur when the immune system mistakenly attacks the body's healthy cells and tissues. This rising prevalence is attributed to factors such as genetic predisposition, environmental influences such as pollution and dietary changes, and greater exposure to infections and stressors that can trigger immune system dysregulation. Autoimmune disorders are advancing panuveitis treatment by promoting research into immune system modulation, as many cases of panuveitis are linked to autoimmune activity. For instance, in May 2023, the University of Oxford, a UK-based research institution, reported that autoimmune disorders affect 10% of the global population, with 13% of women and 7% of men impacted. As a result, the increasing occurrence of autoimmune disorders is fueling the expansion of the panuveitis market.
Leading companies in the panuveitis market are prioritizing the development of advanced slow-release intravitreal injection formulations to enhance patient compliance and treatment effectiveness. A slow-release intravitreal injection formulation is a drug delivery system that gradually administers medication into the eye's vitreous humor over an extended period, ensuring sustained therapeutic effects while minimizing the need for frequent dosing. For example, in August 2022, Tarsier Pharma, an Israel-based clinical-stage company, announced the development of TRS02, a potential immunomodulator for the treatment of retinal diseases. This innovative therapy is designed to address various back-of-the-eye conditions with inflammatory pathologies, including posterior uveitis (panuveitis) and diabetic macular edema. TRS02, developed using Tarsier's proprietary technology platform, is advancing toward investigational new drug (IND) submission following successful preclinical milestones.
In July 2023, Harrow Health Inc., a US-based pharmaceutical company, acquired Santen Pharmaceutical Co., Ltd. for an undisclosed sum. This acquisition enables Harrow to expand its portfolio by integrating Santen's expertise in developing innovative treatments for uveitis and panuveitis. Santen Pharmaceutical Co. Ltd., a Japan-based company, specializes in treatments for panuveitis.
Major players in the panuveitis market are Pfizer Inc., AbbVie, Boehringer Ingelheim International GmbH, Amgen, Teva Pharmaceuticals, Sandoz, Organon group of companies, Zydus Lifesciences Ltd., Mallinckrodt plc, Alvotech, EyePoint Pharmaceuticals Inc., Affibody Medical AB, Alumis Inc., Fujifilm Kyowa Kirin Biologics Co. Ltd., Revolo Biotherapeutics Ltd., Tarsier Pharma, Priovant Therapeutics Inc., Mylan N.V., Clearside Biomedical Inc., pSivida Corp.
North America was the largest region in the panuveitis market in 2024. The regions covered in panuveitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the panuveitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The panuveitis market consists of revenues earned by entities providing services such as pharmaceutical treatment, surgical interventions, diagnostic services, and supportive care. The market value includes the value of related goods sold by the service providers or included within the service offering. The panuveitis market also includes sales of diagnostic tools, pharmaceuticals, biologic agents, immunosuppressive drugs, and supportive care products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Panuveitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on panuveitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for panuveitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The panuveitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Infectious Panuveitis; Non-Infectious Panuveitis
- 2) By Treatment: Pharmacological; Surgical; Phototherapy
- 3) By Route Of Administration: Oral; Intravitreal; Topical
- 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Infectious Panuveitis: Bacterial Panuveitis; Viral Panuveitis; Fungal Panuveitis; Parasitic Panuveitis
- 2) By Non-Infectious Panuveitis: Autoimmune-Related Panuveitis; Idiopathic Panuveitis; Drug-Induced Panuveitis
- Companies Mentioned:Pfizer Inc.; AbbVie; Boehringer Ingelheim International GmbH; Amgen; Teva Pharmaceuticals
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Panuveitis Market Characteristics
3. Panuveitis Market Trends And Strategies
4. Panuveitis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Panuveitis Growth Analysis And Strategic Analysis Framework
- 5.1. Global Panuveitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Panuveitis Market Growth Rate Analysis
- 5.4. Global Panuveitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Panuveitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Panuveitis Total Addressable Market (TAM)
6. Panuveitis Market Segmentation
- 6.1. Global Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infectious Panuveitis
- Non-Infectious Panuveitis
- 6.2. Global Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmacological
- Surgical
- Phototherapy
- 6.3. Global Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Oral
- Intravitreal
- Topical
- 6.4. Global Panuveitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.5. Global Panuveitis Market, Sub-Segmentation Of Infectious Panuveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bacterial Panuveitis
- Viral Panuveitis
- Fungal Panuveitis
- Parasitic Panuveitis
- 6.6. Global Panuveitis Market, Sub-Segmentation Of Non-Infectious Panuveitis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autoimmune-Related Panuveitis
- Idiopathic Panuveitis
- Drug-Induced Panuveitis
7. Panuveitis Market Regional And Country Analysis
- 7.1. Global Panuveitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Panuveitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Panuveitis Market
- 8.1. Asia-Pacific Panuveitis Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Panuveitis Market
- 9.1. China Panuveitis Market Overview
- 9.2. China Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Panuveitis Market
- 10.1. India Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Panuveitis Market
- 11.1. Japan Panuveitis Market Overview
- 11.2. Japan Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Panuveitis Market
- 12.1. Australia Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Panuveitis Market
- 13.1. Indonesia Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Panuveitis Market
- 14.1. South Korea Panuveitis Market Overview
- 14.2. South Korea Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Panuveitis Market
- 15.1. Western Europe Panuveitis Market Overview
- 15.2. Western Europe Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Panuveitis Market
- 16.1. UK Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Panuveitis Market
- 17.1. Germany Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Panuveitis Market
- 18.1. France Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Panuveitis Market
- 19.1. Italy Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Panuveitis Market
- 20.1. Spain Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Panuveitis Market
- 21.1. Eastern Europe Panuveitis Market Overview
- 21.2. Eastern Europe Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Panuveitis Market
- 22.1. Russia Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Panuveitis Market
- 23.1. North America Panuveitis Market Overview
- 23.2. North America Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Panuveitis Market
- 24.1. USA Panuveitis Market Overview
- 24.2. USA Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Panuveitis Market
- 25.1. Canada Panuveitis Market Overview
- 25.2. Canada Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Panuveitis Market
- 26.1. South America Panuveitis Market Overview
- 26.2. South America Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Panuveitis Market
- 27.1. Brazil Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Panuveitis Market
- 28.1. Middle East Panuveitis Market Overview
- 28.2. Middle East Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Panuveitis Market
- 29.1. Africa Panuveitis Market Overview
- 29.2. Africa Panuveitis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Panuveitis Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Panuveitis Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Panuveitis Market Competitive Landscape And Company Profiles
- 30.1. Panuveitis Market Competitive Landscape
- 30.2. Panuveitis Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. AbbVie Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Amgen Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceuticals Overview, Products and Services, Strategy and Financial Analysis
31. Panuveitis Market Other Major And Innovative Companies
- 31.1. Sandoz
- 31.2. Organon group of companies
- 31.3. Zydus Lifesciences Ltd.
- 31.4. Mallinckrodt plc
- 31.5. Alvotech
- 31.6. EyePoint Pharmaceuticals Inc.
- 31.7. Affibody Medical AB
- 31.8. Alumis Inc.
- 31.9. Fujifilm Kyowa Kirin Biologics Co. Ltd.
- 31.10. Revolo Biotherapeutics Ltd.
- 31.11. Tarsier Pharma
- 31.12. Priovant Therapeutics Inc.
- 31.13. Mylan N.V.
- 31.14. Clearside Biomedical Inc.
- 31.15. pSivida Corp.
32. Global Panuveitis Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Panuveitis Market
34. Recent Developments In The Panuveitis Market
35. Panuveitis Market High Potential Countries, Segments and Strategies
- 35.1 Panuveitis Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Panuveitis Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Panuveitis Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
